294 related articles for article (PubMed ID: 30338648)
41. Short-term and low-dose IL-2 therapy restores the Th17/Treg balance in the peripheral blood of patients with primary Sjögren's syndrome.
Miao M; Hao Z; Guo Y; Zhang X; Zhang S; Luo J; Zhao X; Zhang C; Liu X; Wu X; Xu D; Zhao J; Lu X; Gao C; Li X
Ann Rheum Dis; 2018 Dec; 77(12):1838-1840. PubMed ID: 29936436
[No Abstract] [Full Text] [Related]
42. The role of B7 family costimulatory molecules and indoleamine 2,3-dioxygenase in primary Sjögren's syndrome and systemic sclerosis.
Legány N; Berta L; Kovács L; Balog A; Toldi G
Immunol Res; 2017 Jun; 65(3):622-629. PubMed ID: 27878564
[TBL] [Abstract][Full Text] [Related]
43. [Hepatitis B e antigen from chronic hepatitis B patients induces Th1/Th2 cytokine imbalance in vitro].
Han YP; Li J; Jiang LF; Xu QQ; Liu B; Dong L; Chen N; Kong LH; Xie FR; Huang ZH
Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):584-9. PubMed ID: 24119737
[TBL] [Abstract][Full Text] [Related]
44. Expression of programmed cell death-1 and its ligand B7 homolog 1 in peripheral blood lymphocytes from patients with peripartum cardiomyopathy.
Xia G; Zheng X; Yao X; Yao X; Liu Z; Wang J
Clin Cardiol; 2017 May; 40(5):307-313. PubMed ID: 28026044
[TBL] [Abstract][Full Text] [Related]
45. Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome.
Lucchesi D; Coleby R; Pontarini E; Prediletto E; Rivellese F; Hill DG; Derrac Soria A; Jones SA; Humphreys IR; Sutcliffe N; Tappuni AR; Pitzalis C; Jones GW; Bombardieri M
Arthritis Rheumatol; 2020 Sep; 72(9):1559-1570. PubMed ID: 32307922
[TBL] [Abstract][Full Text] [Related]
46. Interferon-β inhibits inflammatory responses mediators via suppression of iNOS signaling pathway in PBMCs from patients with primary Sjögren's syndrome.
Benchabane S; Belkhelfa M; Belguendouz H; Zidi S; Boudjelida A; Youinou P; Touil-Boukoffa C
Inflammopharmacology; 2018 Oct; 26(5):1165-1174. PubMed ID: 29869303
[TBL] [Abstract][Full Text] [Related]
47. Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjogren's syndrome.
Liu MF; Lin LH; Weng CT; Weng MY
Lupus; 2008 Jan; 17(1):34-9. PubMed ID: 18089681
[TBL] [Abstract][Full Text] [Related]
48. Effects of total glucosides of peony on AQP-5 and its mRNA expression in submandibular glands of NOD mice with Sjogren's syndrome.
Wu GL; Pu XH; Yu GY; Li TY
Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):173-8. PubMed ID: 25635992
[TBL] [Abstract][Full Text] [Related]
49. B Cell Depletion Therapy Normalizes Circulating Follicular Th Cells in Primary Sjögren Syndrome.
Verstappen GM; Kroese FG; Meiners PM; Corneth OB; Huitema MG; Haacke EA; van der Vegt B; Arends S; Vissink A; Bootsma H; Abdulahad WH
J Rheumatol; 2017 Jan; 44(1):49-58. PubMed ID: 28042126
[TBL] [Abstract][Full Text] [Related]
50. Combined use of total glucosides of paeony and hydroxychloroquine in primary Sjögren's syndrome: A systematic review.
Zhang A; Chen S; Lin R
Immun Inflamm Dis; 2023 Oct; 11(10):e1044. PubMed ID: 37904705
[TBL] [Abstract][Full Text] [Related]
51. Attenuation of Follicular Helper T Cell-Dependent B Cell Hyperactivity by Abatacept Treatment in Primary Sjögren's Syndrome.
Verstappen GM; Meiners PM; Corneth OBJ; Visser A; Arends S; Abdulahad WH; Hendriks RW; Vissink A; Kroese FGM; Bootsma H
Arthritis Rheumatol; 2017 Sep; 69(9):1850-1861. PubMed ID: 28564491
[TBL] [Abstract][Full Text] [Related]
52. [Expression of PD-1 and PD-L1 in the peripheral blood of advanced non-small-cell lung cancer patients and its implications].
Xing YF; Pan X; Qian B; Shi MH
Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(2):111-114. PubMed ID: 30669748
[No Abstract] [Full Text] [Related]
53. Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18.
Ciccia F; Guggino G; Rizzo A; Bombardieri M; Raimondo S; Carubbi F; Cannizzaro A; Sireci G; Dieli F; Campisi G; Giacomelli R; Cipriani P; De Leo G; Alessandro R; Triolo G
Clin Exp Immunol; 2015 Aug; 181(2):219-29. PubMed ID: 25880879
[TBL] [Abstract][Full Text] [Related]
54. [Protective mechanism of XinFeng capsule on Sojgren syndrome rat pulmonary function based on the TGF-β1-ERK1 signal pathway].
Feng Y; Liu J; Cheng Y; Wan L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):118-22. PubMed ID: 23388327
[TBL] [Abstract][Full Text] [Related]
55. The importance of the PD-1/PD-L1 pathway at the maternal-fetal interface.
Meggyes M; Miko E; Szigeti B; Farkas N; Szereday L
BMC Pregnancy Childbirth; 2019 Feb; 19(1):74. PubMed ID: 30782114
[TBL] [Abstract][Full Text] [Related]
56. Differential interleukin (IL)-10 and IL-13 gene expression in vivo in salivary glands and peripheral blood mononuclear cells from patients with primary Sjögren's syndrome.
Villarreal GM; Alcocer-Varela J; Llorente L
Immunol Lett; 1996 Jan; 49(1-2):105-9. PubMed ID: 8964596
[TBL] [Abstract][Full Text] [Related]
57. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
[TBL] [Abstract][Full Text] [Related]
58. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
[TBL] [Abstract][Full Text] [Related]
59. Endogenous programmed death ligand-1 restrains the development and onset of Sjӧgren's syndrome in non-obese diabetic mice.
Zhou J; Jin JO; Kawai T; Yu Q
Sci Rep; 2016 Dec; 6():39105. PubMed ID: 27966604
[TBL] [Abstract][Full Text] [Related]
60. Clinical efficacy of leflunomide in primary Sjogren's syndrome is associated with regulation of T-cell activity and upregulation of IL-7 receptor α expression.
Bikker A; van Woerkom JM; Kruize AA; van der Wurff-Jacobs KM; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2012 Dec; 71(12):1934-41. PubMed ID: 22563027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
